KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vertex Pharmaceuticals (VRTX) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Vertex Pharmaceuticals (VRTX) over the last 17 years, with Q4 2025 value amounting to $14.4 billion.

  • Vertex Pharmaceuticals' Non-Current Assets rose 1163.5% to $14.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $55.2 billion, marking a year-over-year increase of 1700.09%. This contributed to the annual value of $14.4 billion for FY2025, which is 1163.5% up from last year.
  • Vertex Pharmaceuticals' Non-Current Assets amounted to $14.4 billion in Q4 2025, which was up 1163.5% from $14.3 billion recorded in Q3 2025.
  • Vertex Pharmaceuticals' 5-year Non-Current Assets high stood at $14.4 billion for Q4 2025, and its period low was $3.6 billion during Q1 2021.
  • Over the past 5 years, Vertex Pharmaceuticals' median Non-Current Assets value was $6.8 billion (recorded in 2023), while the average stood at $8.1 billion.
  • As far as peak fluctuations go, Vertex Pharmaceuticals' Non-Current Assets plummeted by 200.28% in 2021, and later soared by 7689.44% in 2024.
  • Over the past 5 years, Vertex Pharmaceuticals' Non-Current Assets (Quarter) stood at $3.9 billion in 2021, then increased by 26.97% to $4.9 billion in 2022, then soared by 74.65% to $8.6 billion in 2023, then skyrocketed by 50.67% to $12.9 billion in 2024, then increased by 11.64% to $14.4 billion in 2025.
  • Its Non-Current Assets was $14.4 billion in Q4 2025, compared to $14.3 billion in Q3 2025 and $13.6 billion in Q2 2025.